Atadja P, Wong H, Garkavtsev I, Veillette C, Riabowol K
Department of Medical Biochemistry, University of Calgary, AB, Canada.
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8348-52. doi: 10.1073/pnas.92.18.8348.
The p53 tumor-suppressor protein binds DNA and activates the expression of a 21-kDa protein that inhibits both the activity of cyclin-dependent kinases and the function of proliferating cell nuclear antigen. Since p21 expression has been reported to increase 10- to 20-fold as human diploid fibroblasts lose the ability to replicate, we examined the expression and activity of p53 during replicative aging. Similar levels of total p53 mRNA and protein were expressed in low-passage (young) and high-passage (old) cells but both DNA binding activity in vitro and transcriptional activity of p53 in vivo were increased severalfold in high-passage cells. While the basis of increased p53 activity is presently unclear, it is not correlated with differential phosphorylation or changes in p53-mouse double minute 2 gene product interactions. These results provide evidence for the activation of a protein involved in the control of cell cycle checkpoints during cellular aging, in the absence of increased expression.
p53肿瘤抑制蛋白与DNA结合并激活一种21 kDa蛋白的表达,该蛋白可抑制细胞周期蛋白依赖性激酶的活性以及增殖细胞核抗原的功能。由于据报道,随着人二倍体成纤维细胞丧失复制能力,p21的表达会增加10至20倍,因此我们研究了复制性衰老过程中p53的表达和活性。低代(年轻)细胞和高代(年老)细胞中p53总mRNA和蛋白的表达水平相似,但高代细胞中p53的体外DNA结合活性和体内转录活性均增加了几倍。虽然目前尚不清楚p53活性增加的基础,但它与磷酸化差异或p53-小鼠双微体2基因产物相互作用的变化无关。这些结果为在细胞衰老过程中,在表达未增加的情况下,参与细胞周期检查点控制的一种蛋白被激活提供了证据。